Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|14|6|494-497

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.14, Iss.6, 2016-10, pp. : 494-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression

By Ramsanahie Anthony   Berger Urs   Zinner Michael   Whang Edward   Rhoads David   Ashley Stanley  

Digestive Diseases and Sciences, Vol. 49, Iss. 11-12, 2004-11 ,pp. : 1731-1737

Springer Publishing Company

Access to resources Recommend Favorite

Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 3, 2013-09 ,pp. : 203-206

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)

By  

Current Vascular Pharmacology, Vol. 14, Iss. 5, 2016-09 ,pp. : 469-473

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 2, 2015-08 ,pp. : 105-112

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

By  

Current Diabetes Reviews, Vol. 12, Iss. 4, 2016-10 ,pp. : 403-413

Bentham Science Publishers

Access to resources Recommend Favorite